Investigational pharmacological treatments for Parkinson’s disease

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Scopus citations

Abstract

Effective therapy for Parkinson’s disease (PD) has existed for 40 years. Currently, levodopa, the precursor to dopamine, remains the most consistently effective medication. Most other pharmacologic treatments, such as dopamine agonists, augment and replace the endogenous dopamine loss that causes PD symptoms. Other treatments such as anticholinergic medications and amantadine often help symptoms through nondopaminergic mechanisms. Numerous other medications such as antidepressants and antipsychotics are used to treat specific symptoms in PD.

Original languageEnglish (US)
Title of host publicationHandbook of Parkinson's Disease, Third Edition
PublisherCRC Press
Pages453-461
Number of pages9
ISBN (Electronic)9780203912164
ISBN (Print)9780824742423
StatePublished - Jan 1 2003

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Investigational pharmacological treatments for Parkinson’s disease'. Together they form a unique fingerprint.

Cite this